|
Interest of a Hybrid Connected Watch for Cardiac Rhythm Monitoring in Post-operative Cardiac Surgery
RECRUITINGSponsored by Nantes University Hospital
Actively Recruiting
SponsorNantes University Hospital
Started2024-03-19
Est. completion2026-03-19
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05664308
Summary
The objective of this single-center pilot study is, with the help of a connected watch, to show the absence of recurrence or maintenance of sinus rhythm in patients with a Post Operative Atrial Fibrillation (POAF) and to help treating cardiologists in the care of these patients.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Major with an indication for conventional cardiac surgery with de novo postoperative AF onset. * Agreeing to participate in the study and having signed an informed consent. * Agreeing to undergo 12 months of postoperative monitoring. Exclusion Criteria: * Patient with pre-operative AF * Patient who does not have a smartphone compatible with the connected watch. * Patient unable to perform an ECG measurement independently. * Patient with a physical constraint to the measurement (arteriovenous fistula...) * Minors * Pregnant or breast-feeding women * Adults under guardianship, under curatorship * Patients whose life expectancy is less than 1 year * Patients participating in another therapeutic trial likely to impact the evaluation criteria of the MONHYCARD study * Contraindication to long-term anticoagulants * Patients implanted with a mechanical valve prosthesis pre-operatively or after surgery
Conditions2
Atrial FibrillationHeart Disease
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorNantes University Hospital
Started2024-03-19
Est. completion2026-03-19
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05664308